Canadian researchers have found a simple cure for cancer, but large pharmaceutical companies are not interested in this.
Researchers from the University of Alberta at Edmonton, Canada, cured cancer, but in the news and on television it was almost not lit up. This is a simple technique using simple medicinal a drug. The method uses dichloroacetate (dichloroacetate), which is currently used to treat metabolic disorders substances. So do not worry about its side effects or long term effects.
A photo from open sources
This drug does not require a patent, so everyone can use its ubiquitous and cheap, and not use expensive drugs from cancers that are created by large pharmaceutical companies.
Canadian scientists tested dichloroacetate on human cells; the drug killed cancer cells in the lungs, breast and brain, but not affected healthy. The drug was tested in rats with severe forms of tumors; their cancer cells shrunk when they became drink water with dichloroacetate. The drug is widely available, the technique of using it is simple, so why is it not interesting large pharmaceutical companies? And why not in this discovery were interested in the media?
In the human body there are natural anti-cancer cells, mitochondria, but in order for them to act, they must be “push”. Scientists are used to thinking that mitochondrial cells damaged and therefore ineffective against cancer. therefore instead, they focused on glycolysis, which is less effective and more devastating to the body. In the fight against cancer manufacturers have relied on the glycolysis method. However method The use of dichloroacetate relies on mitochondria; a drug “Awakens” cells that begin to fight cancer cells.
Pharmaceutical companies do not invest in these research, because the dichloroacetate method cannot be patented, and without a patent they won’t be able to make money, how do they do it now with his patent for treating AIDS.
This article is intended to let the audience know about this study, in the hope that some independent companies or small ones startups will pick up this idea and start producing the drug, because that large companies will not pay for it for a long time Attention.
Oncology
